Genomic medicine leverages an individual’s genetic information to guide healthcare decisions, with drug-gene testing (also known as pharmacogenomics, or PGx) being a key application that personalizes ...

Rose Brystowski, 68, had a choice to make. Others might have found it difficult. She found it easy. Brystowski, of Oak Park, Michigan, wasn't about to let her genetics forfeit her future. Doctors cut ...

BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk ...

Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways There is a hereditary form of transthyretin amyloid cardiomyopathy (ATTR-CM) caused when a mutated gene is passed from parent to child.Having ...

Study results show a new technique that analyzes genomic information from a type of skin cancer tumor could help melanoma patients avoid additional surgery on their lymph nodes. The test was developed ...

Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...

Gene expression testing, such as Oncotype DX, aids in chemotherapy decisions for hormone receptor-positive breast cancer, though challenges exist for premenopausal patients with scores under 25.

“Breast cancer was the furthest thing from my mind,” Jacob Johnson tells PEOPLE ...

Please provide your email address to receive an email when new articles are posted on . Six states are projected to have at least 50 more visits from patients with ALS per year per center. Regardless ...

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Add Yahoo as a preferred source to see more of our stories on Google. Rose Brystowski, 68, had a choice to make. Others might have found it difficult. She found it easy. "My ovaries had retired," she ...